Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 4, 2003, Pages 887-893

  Dobay, Orsolya ^a,b   Rozgonyi, Ferenc ^b   Hajdú, Edit ^c   Nagy, Erzsébet ^c   Knausz, Márta ^d   Amyes, Sebastian G B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Petz Aladar County and Teaching Hospital   (Hungary)

Author keywords

Hungary; Macrolide resistance; Penicillin resistance; Serotyping; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FROPENEM; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; TELITHROMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUNGARY; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; SEROTYPE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; HUNGARY; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0242515958     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg171     Document Type: Article

References (36)

1. Marton, A., Gulyás, M., Munoz, R. & Tomasz, A. (1991). Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. Journal of Infectious Diseases 163, 542-8.
2. Marton, A. (1992). Pneumococcal antimicrobial resistance: the problem in Hungary. Clinical Infectious Diseases 15, 106-11.
3. Marton, A. & Mészner, Z. (1999). Epidemiological studies on drug resistance in Streptococcus pneumoniae in Hungary: an update for the 1990s. Microbial Drug Resistance 5, 201-5.
4. Fenoll, A., Jado, I., Vicioso, D., Pérez, A. & Casal, J. (1998). Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990-1996). Journal of Clinical Microbiology 36, 3447-54.
5. Pérez-Trallero, E., Fernández-Mazarrasa, C., García-Rey, C., Bouza, E., Aguilar, R., García-De-Lomas, J. et al. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: result of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrobial Agents and Chemotherapy 45, 3334-40.
6. Liñares, J., Tubau, F. & Domínguez, M. A. (2000). Antibiotic resistance in Streptococcus pneumoniae in Spain: an overview of the 1990s. In Streptococcus pneumoniae. Molecular Biology & Mechanisms of Disease (Tomasz, A., Ed.), pp. 399-407. Mary Ann Liebert Inc., Larchmont, NY, USA.
7. Annual Reports of the Hungarian Public Health Institute (Johan Béla Országos Egészségügyi Központ Módszertani levelei/A megyei ÁNTSZ laboratóriumok és az egyetemi illetve kórházi mikrobiológiai laboratóriumok éves járványügyi jelentései) (1975-2000).
8. Marton, A. (1997). A Streptococcus pneumoniae antibiotikum rezisztenciája (Hungarian). Infektológia és Klinikai Mikrobiológia 1, 23-8.
9. Marton, A. (1995). Epidemiology of resistant pneumococci in Hungary. Microbial Drug Resistance 1, 127-30.
10. Nagai, K., Shibasaki, Y., Hasegawa, K., Davies, T. A., Jacobs, M. R., Ubukata, K. et al. (2001). Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and β-lactam resistance, and to detect common macrolide resistance determinants. Journal of Antimicrobial Chemotherapy 48, 915-8.
11. National Committee for Clinical Laboratory Standards. (2002). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
12. Nagai, K., Appelbaum, P. C., Davies, T. A., Kelly, L. M., Hoellman, D. B., Tambic Andrasevic, A. et al, (2002). Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries. Antimicrobial Agents and Chemotherapy 46, 371-7.
13. Soussy, C. J., Goldstein, F., Bryskier, A., Drugeon, H., Andrews, J., Baquero, F. et al. (2000). Telithromycin (TEL): assessment of susceptibility testing. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract 321, p. 136. American Society for Microbiology, Washington, DC, USA.
14. MacGowan, A. P. & Wise, R. (2001). Establishing MIC break-points and the interpretation of in vitro susceptibility tests. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 17-28.
15. Balcabao, I. P., Alou, L., Aguilar, R., Gomez-Lus, M. L., Gimenez, M. J. & Prieto, J. (2001). Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new fluoroquinolones. Journal of Antimicrobial Chemotherapy 48, 907-9.
16. García-Rey, C., Aquilar, L. & Baquero, F. (2000). Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain. Antimicrobial Agents and Chemotherapy 44, 3481-2.
17. Schmitz, F. J., Boos, M., Mayer, S., Verhoef, J., Milatovic, D. & Fluit, A. C. (2001). In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 48, 148-52.
18. Tomasz, A. (1999). A multinational workshop on drug-resistant pathogens of the respiratory tract: prevalence, risk factors and intervention strategies. Clinical Microbiology and Infection 5, Suppl. 4, S1-2.
19. Overweg, K., Hermans, P. W. M., Trzcinski, K., Sluijter, M., de Groot, R. & Hryniewicz, W. (1999). Multidrug resistant Streptococcus pneumoniae in Poland: identification of emerging clones. Journal of Clinical Microbiology 37, 1739-45.
20. Szabó, D. (2001). A Streptococcus pneumoniae antibiotikum resistentiája (Hungarian). Antimicrobás Spectrum 4, 8-10.
21. Pradier, C., Dunais, B., Carsenti-Etesse, H. & Dellamonica, P. (1997). Pneumococcal resistance patterns in Europe. European Journal of Clinical Microbiology and Infection 16, 644-7.
22. Felmingham, D., Feldman, C., Hryniewicz, W., Klugman, K., Kohno, S., Low, D. E. et al. (2002). Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clinical Microbiology and Infection 8, Suppl. 1, 12-42.
23. Klugman, K. P. (1990). Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 3, 171-96.
24. McGee, L., Klugman, K. P. & Tomasz, A. (2000). Serotypes and clones of antibiotic-resistant pneumococci. In Streptococcus pneumoniae. Molecular Biology & Mechanisms of Disease (Tomasz, A., Ed.), pp. 375-9. Mary Ann Liebert Inc., Larchmont, NY, USA.
25. Klugman, K. P., Koornhof, H. J. & Kuhnle, V. (1986). Clinical and nasopharyngeal isolates of unusually multiply resistant pneumococci. American Journal of Diseases in Children 140, 1186-90.
26. Perez, J. L., Liñares, J., Bosch, J., Lopez de Giocoechea, M. J. & Martin, R. (1987). Antibiotic resistance in Streptococcus pneumoniae in childhood carriers. Journal of Antimicrobial Chemotherapy 19, 278-80.
27. McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F.C., George, R. et al. (2001). Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. Journal of Clinical Microbiology 39, 2565-71.
28. Gray, B. M., Converse, G. M., III & Dillon, H. C., Jr (1980). Epiedemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. Journal of Infectious Diseases 142, 923-33.
29. Rahal, K., Wang, F., Schindler, J., Rowe, B., Cookson, B., Huovinen, P. et al. (1997). Reports on surveillance of antimicrobial reistance in individual countries. Clinical Infectious Diseases 24, S169-75.
30. Felmingham, D., Grüneberg, R. N. & the Alexander Project Group. (2000). The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 48, 191-203.
31. Corso, A., Severina, E. P., Petruk, V. F., Mauriz, Y. R. & Tomasz, A. (1998). Molecular charcterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory tract disease in the United States. Microbial Drug Resistance 4, 325-37.
32. Kyaw, M. H., Clarke, S., Edwards, G. F., Jones, I. G. & Campbell, H. (2000). Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiology and Infection 125, 561-72.
33. Munoz, R., Musser, J. M., Crain, M., Briles, D. E., Marton, A., Parkinson, A. J. et al. (1992). Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clinical Infectious Diseases 15, 112-8.
34. Joloba, M. L., Windau, A., Bajaksouzian, S., Appelbaum, P. C., Hausdorff, W. P. & Jacobs, M. R. (2001). Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clinical Infectious Diseases 33, 1489-94.
35. Cartwright, K. (2002). Pneumococcal disease in Western Europe: burden of disease, antibiotic resistance and management. European Journal of Pediatrics 61, 188-95.
36. Dagan, R., Yagupsky, P., Goldbart, A., Wasas, A. & Klugman, K.P. (1994). Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatric Infectious Disease Journal 13, 782-6.